KBC Private Partners Life Sciences

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Onderwerp akte: Statutenwijziging - kapitaalvermindering",
      "value": "Statutenwijziging - kapitaalvermindering",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-08-03",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 03/08/2026",
      "value": "03/08/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-27",
      "type": "filing",
      "quote": "neergelegd/ontvangen opd 27 JULI 2026",
      "value": "27/07/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-13",
      "type": "board_meeting",
      "quote": "Uit de notulen van de zaakvoerder d.d. 13 juli 2026",
      "value": "13/07/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "capital_decrease",
      "quote": "kapitaalvermindering werd doorgevoerd ten belope van 8.746.815,92 EUR ... kapitaal van de vennootschap gebracht van 50.823.756,98 EUR op 42.076.941,06 EUR",
      "value": {
        "after": "42.076.941,06 EUR",
        "delta": "8.746.815,92 EUR",
        "amount": 42076941.06,
        "before": "50.823.756,98 EUR",
        "method": "terugbetaling in speci\u00EBn aan de vennoten ... zonder vernietiging van aandelen",
        "currency": "EUR"
      },
      "amount": 8746815.92,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "after": "42.076.941,06 EUR",
        "delta": "8.746.815,92 EUR",
        "before": "50.823.756,98 EUR",
        "method": "terugbetaling in speci\u00EBn aan de vennoten ... zonder vernietiging van aandelen"
      }
    },
    {
      "type": "capital",
      "quote": "Er werden inbrengen gedaan in het Fonds ten belope van twee\u00EBnveertig miljoen zesenzeventig duizend negenhonderd eenenveertig euro en zes cent (42.076.941,06 EUR). Als vergoeding voor de inbrengen werden achtenvijftig miljoen zeshonderd en elf duizend honderd en elf (58.611.111) aandelen zonder vermelding van nominale waarde uitgegeven, waarvan achtenvijftig miljoen zeshonderd en een duizend honderd en elf (58.601.111) van soort A en tienduizend (10.000) aandelen van soort B.",
      "value": {
        "amount": 42076941.06,
        "shares": "58.611.111",
        "currency": "EUR",
        "share_types": [
          {
            "type": "A",
            "count": "58.601.111"
          },
          {
            "type": "B",
            "count": "10.000"
          }
        ]
      },
      "amount": 42076941.06,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "amount": "42.076.941,06 EUR",
        "shares": "58.611.111",
        "share_types": [
          {
            "type": "A",
            "count": "58.601.111"
          },
          {
            "type": "B",
            "count": "10.000"
          }
        ]
      }
    },
    {
      "type": "statute_amendment",
      "quote": "beslist de zaakvoerder ... de tekst van artikel 7 van de statuten te vervangen",
      "value": "Artikel 7 vervangen",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "filing_representative",
      "quote": "Er werd een bijzondere volmacht verleend aan Alix Stockman en alle andere werknemers van Finvision ... teneinde de vereiste bekendmakings- en neerleggingsformaliteiten ... te vervullen",
      "value": "bijzondere volmacht ... teneinde de vereiste bekendmakings- en neerleggingsformaliteiten ... te vervullen",
      "object": "e1",
      "subject": "e2"
    },
    {
      "type": "filing_representative",
      "quote": "Van Berckelaer Tom (voor Finvision Accountancy, Tax \u0026 Legal BV) Bijzonder gevolmachtigde",
      "value": "Bijzonder gevolmachtigde",
      "object": "e1",
      "subject": "e4"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 3278,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0769.268.594",
      "kind": "company",
      "name": "KBC Private Partners Life Sciences",
      "attrs": {
        "seat": "Havenlaan 2, 1080 Sint-Jans-Molenbeek",
        "legal_form": "Commanditaire vennootschap"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Alix Stockman",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "org",
      "name": "Finvision",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "Tom Van Berckelaer",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "company",
      "name": "Finvision Accountancy, Tax \u0026 Legal BV",
      "attrs": {}
    }
  ]
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 50823756.98,
      "delta_eur": -2536199.0,
      "before_eur": 53359955.98,
      "share_emission": {
        "agio_eur": null,
        "share_form": "unknown",
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": "distribution_to_shareholders",
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": 2536199.0,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Luik",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2026-03-02",
    "filing_date": "2026-02-23",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "eenige_bestuurder_schriftelijk",
    "act_date": "2026-02-23",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": "2025-12-18"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0769.268.594",
    "name_full": "KBC Private Partners Life Sciences",
    "legal_form": "Commanditaire vennootschap",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Finvision Accountancy bv",
    "person_name": "Tom Van Berckelaer",
    "org_rep_person_name": "Tom Van Berckelaer",
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "Eensluidend afschrift notulen van de zaakvoerder",
    "Eensluidend afschrift van de geco\u00F6rdineerde statuten"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 58601111,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 10000,
      "class_name": "B",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    }
  ]
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Mazars Bedrijfsrevisoren bv",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "Uit de notulen van de algemene vergadering van 03/06/2025 blijkt de herbenoeming van Mazars Bedrijfsrevisoren bv (0428.837.889), met zetel te 1210 Sint-Joost-ten-Node, Bolwerklaan 21/8 als commissaris van de vennootschap."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0769.268.594",
    "name_full": "KBC PRIVATE PARTNERS LIFE SCIENCES",
    "legal_form": "CommV"
  }
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "amount": 2721130.0,
      "currency": "EUR",
      "after_eur": 53359955.98,
      "delta_eur": -2721130.0,
      "before_eur": 56081085.98,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-09-30",
      "evidence_quote": "Vit de notulen van de zaakvoerder d.d. 30/09/2024 blijkt dat er een kapitaalvermindering werd doorgevoerd ten belope van 2.721.130,00 EUR... Als gevolg van de kapitaalvermindering werd het kapitaal van de vennootschap gebracht van 56.081.085,98 euro op 53.359.955,98 euro",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0769.268.594",
    "name_full": "KBC PRIVATE PARTNERS LIFE SCIENCES",
    "legal_form": "CommV"
  }
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "amount": 2530025.02,
      "currency": "EUR",
      "after_eur": 56081085.98,
      "delta_eur": -2530025.02,
      "before_eur": 58611111.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-02-20",
      "evidence_quote": "Uit de notulen van de zaakvoerder d.d. 20 februari 2024 blijkt dat er een kapitaalvermindering werd doorgevoerd ten belope van 2.530.025,02 EUR, door terugbetaling in speci\u00EBn aan de vennoten van een bedrag gelijk aan het bedrag van de kapitaalvermindering en zonder vernietiging van aandelen. Als gevolg van de kapitaalvermindering werd het kapitaal van de vennootschap gebracht van 58.611.111,00 euro op 56.081.085,98 euro",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0769.268.594",
    "name_full": "KBC PRIVATE PARTNERS LIFE SCIENCES",
    "legal_form": "CommV"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2021-10-27",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0769.268.594",
    "name_full": "KBC PRIVATE PARTNERS LIFE SCIENCES",
    "legal_form": "CommV"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2021-09-15",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0769.268.594",
    "name_full": "KBC PRIVATE PARTNERS LIFE SCIENCES",
    "legal_form": "CommV"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "kind": "oprichting",
  "seat": "1080 Sint-Jans-Molenbeek, Havenlaan 2",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": {
        "kbo": null,
        "name": "KBC Securities"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "A",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": "KBC Securities",
      "contribution_type": "cash",
      "amount_paid_in_eur": 0,
      "holder_person_name": null,
      "is_subscriber_only": false,
      "n_shares_subscribed": 1000,
      "amount_subscribed_eur": 1000,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": null,
        "name": "KBC Bank"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "B",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": "KBC Bank",
      "contribution_type": "cash",
      "amount_paid_in_eur": 0,
      "holder_person_name": null,
      "is_subscriber_only": true,
      "n_shares_subscribed": 10000,
      "amount_subscribed_eur": 10000,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 11000,
  "subject_company": {
    "kbo": "0769.268.594",
    "name_full": "KBC Private Partners Life Sciences",
    "legal_form": "CommV"
  },
  "initial_directors": [],
  "incorporation_date": "2021-06-01",
  "post_incorporation_mandates": []
}